Replies to post #306573 on NorthWest Biotherapeutics Inc (NWBO)

[Hopeforthefuture3]

Senti, totally agree. In my readings yesterday saw estimated (maybe actual) survival as low as 3.5% - this in published papers from 2017 to 2019 so may include temodor. This study should be a winner and good improvement for patients even though it probably does not help all it at least does wonderful things for some
Good luck

[abeta]

Yes Ma'am

If those theoretical 48 patients alive for 60 months were all treatment, as pointed out, that’s almost 21% alive for 5 years. If there were 0 control patients alive for that same time period, that would be a huge indicator of efficacy, IMO.

Moreover, as it stands, over the course of 20 months - 20 treatment
patients died - all occurring after the 36 month part - hmmmmm ....

and all extrapolated from TWO data points past the 36 month point ....

Again - 20 treatment dead in 20 months - all after the 36 month
point .....

we will see .....

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158248042